Gene-editing research has been around for years, but a breakthrough technique
and the global threat of the Zika virus vaulted the idea into mainstream
conversation in 2016 like never before. Now regulators are scrambling with the
question: Should scientists tinker with the blueprints for human life?
Bloomberg's Kaitlin Meehan reports.